Clinical trial
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine…
NCT00440947 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00440947 |
|---|---|
| Title | Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection |
| Official title | See Detailed Description |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r), Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) |
| Enrollment | 515 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Feb 27, 2007 |
| Last update posted | Mar 22, 2012 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: